A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
Clinical trial NCT06023277 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06023277
- Sponsor
- Jacinto Convit World Organization Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.